Salt Lake City, UT (April 5, 2024) The United States Patent and Trademark Office (USPTO) recently awarded 4Life a patent for RioVida
®.
Dr. Brent Vaughan, lead patent inventor: “This patent illustrates our continued effort to offer one-of-a-kind, scientifically validated products that stand out from other supplements. This patent adds to the portfolio for our RioVida line of products. As we continue to advance the transferceutical sciences, we'll also continue to protect that investment with more patents.”
Patent 11,857,593 is a composition patent that protects “a nutraceutical food product [with] a solid matrix and a liquid combined into a gel. The nutraceutical food product may include an immune modulator, such as transfer factor and/or a nanofraction immune modulator. A fruit component (like açaí) may be included in the nutraceutical food product.”
U.S. Patent 11,857,593 joins the company’s collection of more than eighty U.S. and international patents designed to protect 4Life products and, by extension, distinguish 4Life Affiliate businesses. The company also has dozens of patents pending to protect 4Life innovations for future generations.
4Life, The Immune System Company
®, and the first to bring transfer factor research to market, has offices in dozens of countries to serve the company’s worldwide customers.
For more information:
Calvin Jolley
Vice President Corporate Communications
4Life Research
[email protected]
